About Algorithmic Biologics
Algorithmic Biologics is a company based in Bengaluru (India) founded in 2021 by Manoj Gopalkrishnan. Algorithmic Biologics has raised $2.84 million across 3 funding rounds from investors including Bharat Fund and Axilor Ventures. The company has 1 employees as of April 02, 2024. Algorithmic Biologics operates in a competitive market with competitors including Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
- Headquarter Bengaluru, India
- Employees 1 as on 02 Apr, 2024
- Founders Manoj Gopalkrishnan
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Algorithmic Biologics Private Limited
- Date of Incorporation 03 Mar, 2021
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$46.14 K (USD)-1.31as on Mar 31, 2023
-
Net Profit
-$69.34 K (USD)-20.78as on Mar 31, 2023
-
EBITDA
-$111.97 K (USD)-86.75as on Mar 31, 2023
-
Total Equity Funding
$2.84 M (USD)
in 3 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Nov 23, 2023
-
Investors
Bharat Fund
& 1 more
-
Employee Count
1
as on Apr 02, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Algorithmic Biologics
Algorithmic Biologics has successfully raised a total of $2.84M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Algorithmic Biologics
Algorithmic Biologics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bharat Fund and Axilor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding for IP-driven deep-tech and digitization-led inclusive solutions.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage startups in technology sectors.
|
Locked | Locked | Locked |
Investor details for Algorithmic Biologics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Algorithmic Biologics
Investment portfolio details for Algorithmic Biologics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Algorithmic Biologics
Detailed financials for Algorithmic Biologics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Algorithmic Biologics Comparisons
Peer comparison for Algorithmic Biologics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Algorithmic Biologics
Algorithmic Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| Locked | Locked | Locked |
Developer of drugs to treat various diseases
|
|
| Locked | Locked | Locked |
Provider of machine language and computational platform for drug discovery
|
|
| Locked | Locked | Locked |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| Locked | Locked | Locked |
Digital technology for biomedicinal molecule development in research is utilized.
|
Detailed competitors of Algorithmic Biologics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Algorithmic Biologics
Complete news archive for Algorithmic Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Algorithmic Biologics
Algorithmic Biologics was founded in 2021.
Algorithmic Biologics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Manoj Gopalkrishnan is the current CEO of Algorithmic Biologics. They have also founded this company.
Algorithmic Biologics is a funded company, having raised a total of $2.84M across 3 funding rounds to date.
As of Apr 02, 2024, the latest employee count at Algorithmic Biologics is 1.
Annual revenue of Algorithmic Biologics is $46.14K as on Mar 31, 2023.
Provider of software solutions for molecular diagnostics and discovery. The company offers Tapestry that integrates with standard molecular testing workflows, enabling the execution of computing applications that enhance molecular testing.
Algorithmic Biologics has 2 investors. Key investors include Bharat Fund, and Axilor Ventures.
The valuation of Algorithmic Biologics is $10.93M as of Nov 2023.